Identification of a His54Gln substitution in von Willebrand factor from a patient with defective binding of factor VIII

American Journal of Hematology

Volumn 51, Issue 4, 1996, Pages 302-306

  Rick, Margaret E ^a   Krizek, Dennis M ^a  

^a NATIONAL INSTITUTES OF HEALTH   (United States)

Author keywords

Factor VIII binding defect; Genetic defect; Normandy variant; Von Willebrand factor

Indexed keywords

BLOOD CLOTTING FACTOR 8; DESMOPRESSIN; VON WILLEBRAND FACTOR;

ADULT; AMINO ACID SUBSTITUTION; ARTICLE; BLOOD CLOTTING DISORDER; CASE REPORT; FEMALE; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; PRIORITY JOURNAL; VON WILLEBRAND DISEASE;

EID: 0029867787     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(sici)1096-8652(199604)51:4<302::aid-ajh9>3.3.co;2-7     Document Type: Article

References (39)

1. Weiss HJ, Sussman I, Hoyer LW: Stabilization of factor VIII in plasma by the von Willebrand factor. Studies on posttransfusion and dissociated factor VIII and in patients with von Willebrand's disease. J Clin Invest 60:390, 1977.
2. Brinkhous KM, Sandberg H, Garris JB, Mattsson C, Palm M, Griggs T, Read MS: Purified human factor VIII procoagulant protein: Comparative hemostatic response after infusions into hemophilic and von Willebrand disease dogs. Proc Natl Acad Sci USA 82:8752, 1985.
3. Ruggeri Z, Ware J: von Willebrand factor. FASEB J 7:308, 1993.
4. Weiss HJ, Kochwa S: Molecular forms of antihemophilic globulin in plasma, cryoprecipitate and after thrombin activation. Br J Haematol 18:89, 1970.
5. Rick ME, Hoyer LW: Immunologic studies of antihemophilic factor (AHF, factor VIII). V. Immunologic properties of AHF subunits produced by salt dissociation. Blood 42:737, 1973.
6. Koedam JA, Meijers JCM, Sixma JJ, Bouma JN. Inactivation of human factor VIII by activated protein C: Cofactor activity of protein S and protective effect of von Willebrand factor. J Clin Invest 82:1236, 1988.
7. Rick ME, Esmon NL, Krizek DM: Factor IXa and von Willebrand factor modify the inactivation of factor VIII by activated protein C. J Lab Clin Med 115:415, 1990.
8. Fay PJ, Coumans JV, Walker FJ: von Willebrand factor mediates protection of factor VIII from activated protein C-catalyzed inactivation. J Biol Chem 266:2172, 1991.
9. Koedam JA, Hamer RJ, Beeser-Visser NH, Bouma BN, Sixma JJ: The effect of von Willebrand factor on activation of factor VIII by factor Xa. Eur J Biochem 189:229, 1990.
10. Foster PA, Fulcher CA, Marti T, Titani K, Zimmerman TS: A major factor VIII binding domain resides within the amino terminal 272 amino acid residues of von Willebrand factor. J Biol Chem 262:8443, 1987.
11. Takahashi Y, Kalafatis M, Girma JP, Serwin K, Andersson LO, Meyer D: Localization of a factor VIII binding domain on a 34 kDa fragment of the N-terminal portion of von Willebrand factor. Blood 70.1679, 1987.
12. Bahou WF, Ginsburg D, Sikkink R, Litwiller R, Fass DN: A monoclonal antibody to von Willebrand factor (vWf) inhibits factor VIII binding. Localization of its antigenic determinant to a nonadecapeptide at the amino terminus of the mature vWf polypeptide. J Clin Invest 84:56, 1989.
13. Ginsburg D, Sadler JE: von Willebrand disease: A database of point mutations, insertions, and deletions. Thromb Haemost 69:177, 1993.
14. Mazurier C, Dieval J, Jorieux S, Delobel J, Goudemand M: A new von Willebrand factor (vWF) defect in a patient with factor VIII (FVIII) deficiency but with normal levels and multimeric patterns of both plasma and platelet vWF. Characterization of abnormal vWF/FVIII interaction. Blood 75:20, 1990.
15. Mazurier C, Gaucher C, Jorieux S, Goudemand M, et al: Biological effect of desmopressin in eight patients with type 2N ("Normandy") von Willebrand disease. Br J Haematol 88:849, 1994.
16. Sadler JE: A revised classification of von Willebrand disease. Thromb Haemost 71:520, 1994.
17. Kroner PA, Fahs SA, Vokac EA, Friedman KD, Montgomery RR: Novel missense mutations in von Willebrand factor (VWF) associated with defective VWF/factor VIII interaction in a patient with type I von Willebrand disease. Blood 78(suppl 1):178a, 1991.
18. Piao YC, Lavergne JM, Girma JP, Rothchild C, Sie P, Vahnak BR, Meyer D: Study of the factor VIII-binding domain of von Willebrand factor in 55 patients with various types of von Willebrand disease. Thromb Haemost 69:559, 1993.
19. Breckenridge RT, Ratnoff OD: Studies on the nature of the circulating anticoagulant directed against antihemophilic factor: With notes on an assay for antihemophilic factor. Blood 20.137, 1962.
20. Lazarchick J, Hoyer LW: Immunoradiometric measurement of the factor VIII procoagulant antigen. J Clin Invest 62:1048, 1978.
21. Allain JP, Cooper HA, Wagner RH, Brinkhous KM: Platelets fixed with paraformaldehyde: A new reagent for assay of von Willebrand factor and platelet aggregating factor. J Lab Clin Med 85:318, 1975.
22. Hoyer LW: Immunologic studies of antihemophilic factor (AHF, factor VIII). IV. Radioimmunoassay of AHF antigen. J Lab Clin Med 80:822, 1972.
23. Hoyer LW, Shainoff JR: Factor VIII-related protein circulates in normal human plasma as high molecular weight multimers. Blood 55:1056, 1980.
24. Gralnick HR, Williams SB, McKeown LP, Krizek DM, Shafer BC, Rick ME: Platelet von Willebrand factor: Comparison with plasma von Willebrand factor. Thromb Res 38:623, 1985.
25. Nishino M, Girma JP, Rothchild C, Fressinaud E, Meyer D: A new variant of von Willebrand disease with defective binding to factor VIII. Blood 74:1591, 1989.
26. Sambrook J, Fritsch EF, Maniatis T: Analysis and cloning of eukaryotic genomic DNA. In Nolan C (ed): "Molecular Cloning. A Laboratory Manual." Plainview, NY: Cold Spring Harbor Laboratory Press, 1989.
27. Sadler JE, Ginsburg D: A database of polymorphisms in the von Willebrand factor gene and pseudogene. Thromb Haemost 69:185-191, 1993.
28. Nichols RC, Raben N. Hints for direct sequencing of PCR-generated single-stranded DNA. Biotechniques 17:412, 1994.
29. Gaucher C, Jorieux B, Mercier B, Oufkir D, Mazurier C: The "Normandy" variant of von Willebrand disease: Characterization of a point mutation in the von Willebrand factor gene. Blood 77:1937, 1991.
30. Gaucher C, Mercier B, Jorieux B, Oufkir D, Mazurier C: Identification of two point mutations in the von Willebrand factor gene of three families with the "Normandy" variant of von Willebrand disease. Br J Haematol 78:506, 1991.
31. Cacheris PM, Nichols WC, Ginsburg D: Molecular characterization of a unique von Willebrand disease variant. J Biol Chem 266:13499, 1991
32. Kroner PA, Friedman KD, Fahs SA, Scott JP, Montgomery RR: Abnormal binding of factor VIII is linked with the substitution of glutamine for arginine 91 in von Willebrand factor in a variant form of von Willebrand disease. J Biol Chem 266:19146, 1991.
33. Peerlink K, Eikenboom JCJ, Ploos Van Amstel HK, Sangtawesin W, Arnout J, Reitsma PH, Vermylen J, Briet E: A patient with von Willebrand's disease characterized by a compound heterozygosity for a substitution of Arg854 by Gln in the putative factor-VIII-binding domain of von Willebrand factor (vWF) on one allele and very low levels of mRNA from the second vWF allele. Br J Haematol 80:358, 1992.
34. Lavergne JM, Piao Y, Ribba AS, Girma JP, Siguret V, Pietu G, Boyer-Neumann C, Schandelong A, Bahnak BR, Meyer D: Functional analysis, of the Arg91Gln substitution in the factor VIII binding domain of von Willebrand factor demonstrates variable phenotypic expression. Thromb Haemost 70:691, 1993.
35. Siguret V, Lavergne JM, Cherel G, Boyer-Neumann C, Ribba AS, Bahnak BR, Meyer D, Pietu G: A novel case of compound heterozygosity with "Normandy"/type I von Willebrand disease (vWD). Direct demonstration of the segregation of one allele with a defective expression at the mRNA level causing type I vWD. Hum Genet 93:95, 1994.
36. Tuley EA, Gaucher C, Jorieux S, Worrall NK, Sadler JE, Mazurier C: Expression of von Willebrand factor "Normandy". An autosomal mutation that mimics hemophilia A. Proc Natl Acad Sci USA 88:6377, 1991.
37. Jorieux S, Tuley EA, Gaucher C, Mazurier C, Sadler JE: The mutation Arg(53) → Trp causes von Willebrand disease Normandy by abolishing binding to factor VIII. Studies with recombinant von Willebrand factor. Blood 79:563, 1992.
38. Cacheris PM, Nichols WC, Ginsburg D: Identification of von Willebrand factor (vWF) amino acid residues critical for factor VIII (FVIII) binding. Thromb Haemost 69.558, 1993.
39. Jorieux S, Hilbert L, Mazurier C: The use of site directed mutagenesis of von Willebrand factor to elucidate the mechanism of its interaction with factor VIII. Thromb Haemost 69:558, 1993.